News
Abbott gets EU approval of Crohn’s disease drug
Fri, 08/31/2012 - 12:00am
A drug approved to treat moderately-active Crohn’s disease, a chronic inflammatory bowel disease of the gastrointestinal tract, in the European Union has been approved to treat severely active patients with the disease.
